Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc clinical trials

Explore recruiting recurrent metastatic r m head and neck squamous cell carcinoma hnscc clinical trials.

Recruiting recurrent metastatic r m head and neck squamous cell carcinoma hnscc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A single-arm phase II study of cetuximab plus platinum and taxane-based chemotherapy followed by AVElumab and Cetuximab as first-line therapy for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients with PD-L1 combined positive score (CPS)≥1≤19: the immunotherapy.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc trials by city

Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Toronto Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Vancouver Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Montreal Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Calgary Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Edmonton Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Ottawa Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Winnipeg Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Quebec City Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Hamilton Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Kitchener Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in London Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Halifax Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in New York Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Los Angeles Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Chicago Recurrent Metastatic R M Head And Neck Squamous Cell Carcinoma Hnscc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease